Prediction of recurrent heart failure hospitalizations and mortality using the echocardiographic Killip score.
Echocardiography
Heart failure readmissions
Killip score
Prediction
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
received:
29
02
2024
accepted:
24
05
2024
medline:
3
6
2024
pubmed:
3
6
2024
entrez:
3
6
2024
Statut:
aheadofprint
Résumé
Examine the performance of a simple echocardiographic "Killip score" (eKillip) in predicting heart failure (HF) hospitalizations and mortality after index event of decompensated HF hospitalization. HF patients hospitalized at our facility between 03/2019-03/2021 who underwent an echocardiography during their index admission were included in this retrospective analysis. The cohort was divided into 4 classes of eKillip according to: stroke volume index (SVI) < 35ml/m Included 751 patients, median age 78.1 (IQR 69.3-86) years, 59% men, left ventricular ejection fraction 45 (IQR 30-60)%, brain natriuretic peptide levels 634 (IQR 331-1222)pg/ml. Compared with eKillip Class I, a graded increase in the combined endpoint of 30-day mortality and rehospitalizations rates was noted: (Class II: HR 1.77, CI 0.95-3.33, p = 0.07; Class III: HR 1.94, CI 1.05-3.6, p = 0.034; Class IV: HR 2.9, CI 1.64-5.13, p < 0.001 respectively), which overall persisted after correction for clinical (Class II: HR 1.682, CI 0.9-3.15, p = 0.105; Class III: HR 2.104, CI 1.13-3.9, p = 0.019; Class IV: HR 2.74, CI 1.54-4.85, p = 0.001 respectively) or echocardiographic parameters (Class II: HR 1.92, CI 1.02-3.63, p = 0.045; Class III: HR 1.54, CI 0.81-2.95, p = 0.189; Class IV: HR 2.04, CI 1.1-3.76, p = 0.023 respectively). Specifically, the eKillip Class IV group comprised one-third of the patient population and persistently showed increased risk of 30-day HF hospitalizations or mortality following multivariate analysis. A simple echocardiographic score can assist identifying high-risk decompensated HF patients for recurrent hospitalizations and mortality.
Identifiants
pubmed: 38829411
doi: 10.1007/s00392-024-02473-8
pii: 10.1007/s00392-024-02473-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Osenenko KM, Kuti E, Deighton AM, Pimple P, Szabo SM (2022) Burden of hospitalization for heart failure in the United States: a systematic literature review. J Manag Care Spec Pharm 28:157–167
pubmed: 35098748
Killip T, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit: a Two year experience with 250 patients. Am J Cardiol 20:457–464
doi: 10.1016/0002-9149(67)90023-9
pubmed: 6059183
El-Menyar A, Zubaid M, AlMahmeed W et al (2012) Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. Am J Emerg Med 30:97–103
doi: 10.1016/j.ajem.2010.10.011
pubmed: 21159479
Khot UN, Jia G, Moliterno DJ et al (2003) Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290:2174–2181
doi: 10.1001/jama.290.16.2174
pubmed: 14570953
Launbjerg J, Berning J, Fruergaard P et al (1992) Risk stratification after acute myocardial infarction by means of echocardiographic wall motion scoring and Killip classification. Cardiology 80:375–381
doi: 10.1159/000175028
pubmed: 1451125
DeGeare VS, Boura JA, Grines LL, O’Neill WW, Grines CL (2001) Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 87:1035–1038
doi: 10.1016/S0002-9149(01)01457-6
pubmed: 11348598
Milwidsky A, Greidinger D, Frydman S et al (2022) Echocardiographic Killip classification. J Am Soc Echocardiogr 35:287–294
doi: 10.1016/j.echo.2021.10.012
pubmed: 34767929
Dini FL, Carluccio E, Bitto R, Working Group on Heart Failure of the Italian Society of Cardiology et al (2022) Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. ESC Heart Fail 9(2):1107–1117. https://doi.org/10.1002/ehf2.13779
doi: 10.1002/ehf2.13779
pubmed: 35122477
pmcid: 8934975
Carluccio E, Dini FL, Bitto R, Working Group on Heart Failure of the Italian Society of Cardiology et al (2022) Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: an echocardiographic study. Int J Cardiol 350:62–68. https://doi.org/10.1016/j.ijcard.2022.01.004
doi: 10.1016/j.ijcard.2022.01.004
pubmed: 34998946
McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42:3599–3726
doi: 10.1093/eurheartj/ehab368
pubmed: 34447992
Mitchell C, Rahko PS, Blauwet LA et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr 32:1–64
doi: 10.1016/j.echo.2018.06.004
pubmed: 30282592
Ommen SR, Nishimura RA, Appleton CP et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102(15):1788–1794. https://doi.org/10.1161/01.cir.102.15.1788
doi: 10.1161/01.cir.102.15.1788
pubmed: 11023933
Okura H, Kubo T, Asawa K et al (2009) Elevated E/E’ predicts prognosis in congestive heart failure patients with preserved systolic function. Circ J 73(1):86–91. https://doi.org/10.1253/circj.cj-08-0457
doi: 10.1253/circj.cj-08-0457
pubmed: 19015586
Okura H, Takada Y, Kubo T et al (2006) Tissue Doppler-derived index of left ventricular filling pressure, E/E’, predicts survival of patients with non-valvular atrial fibrillation. Heart 92(9):1248–1252. https://doi.org/10.1136/hrt.2005.082594
doi: 10.1136/hrt.2005.082594
pubmed: 16449507
pmcid: 1861171
Patel HN, Miyoshi T, Addetia K et al (2021) Normal values of cardiac output and stroke volume according to measurement technique, age, sex, and ethnicity: results of the world alliance of societies of echocardiography study. J Am Soc Echocardiogr 34:1077-1085 e1
doi: 10.1016/j.echo.2021.05.012
pubmed: 34044105
pmcid: 9149664
Simpson J, Jhund PS, Lund LH et al (2020) Prognostic models derived in PARADIGM-HF and validated in atmosphere and the Swedish heart failure registry to predict mortality and morbidity in chronic heart failure. JAMA Cardiol 5:432–441
doi: 10.1001/jamacardio.2019.5850
pubmed: 31995119
pmcid: 6990745
Bradley J, Schelbert EB, Bonnett LJ et al (2022) Predicting hospitalisation for heart failure and death in patients with, or at risk of, heart failure before first hospitalisation: a retrospective model development and external validation study. Lancet Digit Health 4:e445–e454
doi: 10.1016/S2589-7500(22)00045-0
pubmed: 35562273
pmcid: 9130210
Rich JD, Burns J, Freed BH, Maurer MS, Burkhoff D, Shah SJ (2018) Meta-analysis global group in chronic (MAGGIC) heart failure risk score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction. J Am Heart Assoc 7:e009594
doi: 10.1161/JAHA.118.009594
pubmed: 30371285
pmcid: 6474968
Abraham WT, Stevenson LW, Bourge RC et al (2016) Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 387:453–461
doi: 10.1016/S0140-6736(15)00723-0
pubmed: 26560249
Perl L, Meerkin D, D’Amario D et al (2022) The V-LAP system for remote left atrial pressure monitoring of patients with heart failure: remote left atrial pressure monitoring. J Cardiac Fail 28:963–972
doi: 10.1016/j.cardfail.2021.12.019
Feijen M, Egorova AD, Treskes RW, Mertens BJA, Jukema JW, Schalij MJ, Beeres SLMA (2022) Performance of a HeartLogicTM based care path in the management of a real-world chronic heart failure population. Front Cardiovasc Med 9:883873. https://doi.org/10.3389/fcvm.2022.883873
Taylor CJ, Lay-Flurrie SL, Ordóñez-Mena JM et al (2022) Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018. Heart 108:543–549
doi: 10.1136/heartjnl-2021-319196
pubmed: 34183432
Zile MR, Desai AS, Agarwal R et al (2020) Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population. Clin Cardiol 43:1501–1510
doi: 10.1002/clc.23468
pubmed: 32949178
pmcid: 7724209
Wessler BS, Kramer DG, Kelly JL et al (2011) Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction. Circ Heart Fail 4:578–588
doi: 10.1161/CIRCHEARTFAILURE.111.961573
pubmed: 21705485
Liang HY, Cauduro SA, Pellikka PA et al (2006) Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol 97:866–871
doi: 10.1016/j.amjcard.2005.09.136
pubmed: 16516591
Saito M, Negishi K, Eskandari M et al (2015) Association of left ventricular strain with 30-day mortality and readmission in patients with heart failure. J Am Soc Echocardiogr 28:652–666
doi: 10.1016/j.echo.2015.02.007
pubmed: 25783858
Thavendiranathan P, Yingchoncharoen T, Grant A et al (2014) Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. Am J Cardiol 113:335–341
doi: 10.1016/j.amjcard.2013.09.025
pubmed: 24268036
Liu D, Hu K, Lau K et al (2021) Impact of diastolic dysfunction on outcome in heart failure patients with mid-range or reduced ejection fraction. ESC Heart Failure 8:2802–2815
doi: 10.1002/ehf2.13352
pubmed: 33932134
pmcid: 8318417
AlJaroudi W, Alraies MC, Halley C et al (2012) Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 125:782–788
doi: 10.1161/CIRCULATIONAHA.111.066423
pubmed: 22261198
Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087
doi: 10.1001/archinternmed.2011.244
pubmed: 21709107
Lüers C, Edelmann F, Wachter R et al (2017) Prognostic impact of diastolic dysfunction in systolic heart failure-a cross-project analysis from the German competence network heart failure. Clin Cardiol 40:667–673
doi: 10.1002/clc.22710
pubmed: 28467622
pmcid: 6490547
Maor E, Beigel R, Grupper A, Kuperstein R, Hai I, Medvedofsky D, Perelstein O, Mazin I, Ziv A, Goldenberg I, Feinberg MS, Ben Zekry S (2014) Relation between stroke volume index to risk of death in patients with low-gradient severe aortic stenosis and preserved left ventricular function. Am J Cardiol 114(3):449–455. https://doi.org/10.1016/j.amjcard.2014.05.014
doi: 10.1016/j.amjcard.2014.05.014
pubmed: 24948491
Mele D, Pestelli G, Molin DD et al (2020) Echocardiographic evaluation of left ventricular output in patients with heart failure: a per-beat or per-minute approach? J Am Soc Echocardiogr 33(135–147):e3
Jentzer JC, Wiley BM, Anavekar NS et al (2021) Noninvasive hemodynamic assessment of shock severity and mortality risk prediction in the cardiac intensive care unit. JACC Cardiovasc Imaging 14:321–332
doi: 10.1016/j.jcmg.2020.05.038
pubmed: 32828777